Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners
Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing [...]
Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing [...]
NEW YORK (GenomeWeb) Rna Diagnostics, a Canadian molecular diagnostics company, recently commenced a clinical trial to validate an assay it [...]
Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced enrollment of the [...]
Rna Diagnostics Inc. announced today that Dr. Matthew P. Goetz, Consultant and Professor at Mayo Clinic, Rochester, MN has [...]
Rna Diagnostics announced the launch of an international prospective clinical trial to validate the RNA Disruption Assay™ (RDA™) as a [...]
A new study provides further evidence that the Rna Disruption Assay™ (RDA™) may be a useful tool to predict the [...]
Rna Diagnostics Inc. appoints Dr. Jeremy Bridge-Cook President and CEO Dr. Ken Pritzker, on behalf of the Board of Directors [...]
Rna Diagnostics announces the publication of a study on February 24 2016 in the journal BMC Cancer entitled RNA disruption is [...]
Rna Diagnostics Inc. announced today that Paul Lucas, an accomplished veteran of the Life Sciences industry, has joined the Company’s [...]
The Ontario Institute for Cancer Research and MaRS Discovery District hosted an event for World Cancer Day under the banner [...]